Vireo Growth Inc. (VREOF) stock
VREOFOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 11/30
$9.01+0.01 (+0.11%)
Close on Oct 19, 2026Market cap $406.23MP/E –Yield –
Vireo Growth operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Vireo Growth's operating cash flow for the twelve months ending Jun 30, 2026 was $26.21M. For fiscal 2025 it was $3.71M. The highest annual figure on record is $3.71M in fiscal 2025.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.71M | – |
| FY2024 | Dec 31, 2024 | -$10.23M | – |
| FY2023 | Dec 31, 2023 | -$965.91K | – |
| FY2022 | Dec 31, 2022 | -$18.07M | – |
| FY2021 | Dec 31, 2021 | -$30.52M | – |
| FY2020 | Dec 31, 2020 | -$10.93M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $2.40M | – |
| Q1 FY2026 | Mar 31, 2026 | $11.90M | – |
| Q4 FY2025 | Dec 31, 2025 | $18.66M | – |
| Q3 FY2025 | Sep 30, 2025 | -$6.74M | – |
| Q2 FY2025 | Jun 30, 2025 | -$4.80M | – |
| Q1 FY2025 | Mar 31, 2025 | -$3.40M | – |
| Q4 FY2024 | Dec 31, 2024 | -$6.44M | – |
| Q3 FY2024 | Sep 30, 2024 | -$2.59M | -256.6% |
| Q2 FY2024 | Jun 30, 2024 | -$9.54K | -100.6% |
| Q1 FY2024 | Mar 31, 2024 | -$1.19M | – |
| Q4 FY2023 | Dec 31, 2023 | -$459.54K | – |
| Q3 FY2023 | Sep 30, 2023 | $1.66M | – |
| Q2 FY2023 | Jun 30, 2023 | $1.63M | – |
| Q1 FY2023 | Mar 31, 2023 | -$3.79M | – |
| Q4 FY2022 | Dec 31, 2022 | -$6.12M | – |
| Q3 FY2022 | Sep 30, 2022 | -$2.11M | – |
| Q2 FY2022 | Jun 30, 2022 | -$3.09M | – |
| Q1 FY2022 | Mar 31, 2022 | -$6.76M | – |
| Q4 FY2021 | Dec 31, 2021 | -$7.80M | -12398.1% |
| Q3 FY2021 | Sep 30, 2021 | -$5.23M | – |
| Q2 FY2021 | Jun 30, 2021 | -$12.52M | – |
| Q1 FY2021 | Mar 31, 2021 | -$4.97M | – |
| Q4 FY2020 | Dec 31, 2020 | $63.39K | – |
| Q3 FY2020 | Sep 30, 2020 | -$3.51M | – |
| Q2 FY2020 | Jun 30, 2020 | -$4.76M | – |
| Q1 FY2020 | Mar 31, 2020 | -$2.73M | – |
See a number that looks wrong?